Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Perspective TherapeuticsFRA:AAJ0 -9.08%33 PB Ratio is 0.93 as of Jul. 19, 2026, which is 62% below its 10-year median of 2.43. GuruFocus rates FRA:AAJ0 with a GF Score™ of 33/100. The stock has 2 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Perspective Therapeutics ranks better than 80.03% on this metric.
The historical rank and industry rank for Perspective Therapeutics's PB Ratio or its related term are showing as below:
FRA:AAJ0'
s PB Ratio Range Over the Past 10 Years
Min: 0.51 Med: 2.43 Max: 15.3
Current: 0.98
During the past 13 years, Perspective Therapeutics's highest PB Ratio was 15.30. The lowest was 0.51. And the median was 2.43.
FRA:AAJ0's PB Ratio is ranked better than 80.03% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 2.04
vs FRA:AAJ0: 0.98
During the past 12 months, Perspective Therapeutics's average Book Value Per Share Growth Rate was -20.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -4.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 32.40% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 1.00% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Perspective Therapeutics was 74.60% per year. The lowest was -49.20% per year. And the median was 8.85% per year.
Back to Basics: PB Ratio
Perspective Therapeutics (FRA:AAJ0) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Perspective Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Perspective Therapeutics PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Perspective Therapeutics's PB Ratio distribution charts can be found below:
* The bar in red indicates where Perspective Therapeutics's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Perspective Therapeutics (FRA:AAJ0) has a PB Ratio of 0.93 as of Jul. 19, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Perspective Therapeutics and its competitors. This is 62% below median its historical median of 2.43. Over the past decade, Perspective Therapeutics' PB Ratio has ranged from 0.51 to 15.30. According to the industry distribution chart, Perspective Therapeutics ranks #157 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 20%.
Is Perspective Therapeutics' PB Ratio too high?
Perspective Therapeutics' current PB Ratio of 0.93 is 62% below median its 10-year median of 2.43. Over the past 10 years, this metric has ranged from a low of 0.51 to a high of 15.30. The Medical Devices & Instruments industry median PB Ratio is 2.04. Perspective Therapeutics' value of 0.93 is 54.4% below this industry median. Based on the distribution chart, Perspective Therapeutics ranks #157 out of 786 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Perspective Therapeutics has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Perspective Therapeutics' PB Ratio compare to ELMD and MASS?
According to the Medical Devices & Instruments industry distribution chart, Perspective Therapeutics ranks #157 out of 786 companies for PB Ratio. This places Perspective Therapeutics in the top 20% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.04. Perspective Therapeutics' value of 0.93 is 54.4% below this benchmark. Historically, Perspective Therapeutics' own PB Ratio has ranged from 0.51 to 15.30 over the past decade. While the company's 10-year median is 2.43 vs. the industry median of 2.04, Perspective Therapeutics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.04, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Perspective Therapeutics's current PB Ratio of 0.93 is 54.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Perspective Therapeutics and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Perspective Therapeutics's current PB Ratio is 0.93, which is 62% below median its own 10-year median of 2.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perspective Therapeutics stock overvalued right now?
Perspective Therapeutics (FRA:AAJ0) has a current PB Ratio of 0.93. The current PB Ratio is 0.93, which is 62% below median its 10-year median of 2.43 and 54.4% below the Medical Devices & Instruments industry median of 2.04. Perspective Therapeutics' overall GF Score™ is 33/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Perspective Therapeutics (FRA:AAJ0), the current PB Ratio is 0.93 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
33GF Score
Get the complete analysis for FRA:AAJ0
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:AAJ0 has been successfully added to your 
